Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Mercado Continuo Espanol  >  FAES Farma SA    FAE   ES0134950F36

End-of-day quote. End-of-day quote  - 07/22
3.28 EUR   -4.93%
06/28 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
3.295(c) 3.49(c) 3.7(c) 3.45(c) 3.28 Last
342 095 905 909 1 473 577 1 581 876 615 030 Volume
+4.11% +5.92% +6.02% -6.76% -4.93% Change
More quotes
Financials (€)
Sales 2016 226 M
EBIT 2016 44,6 M
Net income 2016 35,0 M
Finance 2016 45,5 M
Yield 2016 1,63%
Sales 2017 242 M
EBIT 2017 59,0 M
Net income 2017 46,0 M
Finance 2017 71,0 M
Yield 2017 2,29%
P/E ratio 2016 23,77
P/E ratio 2017 16,94
EV / Sales2016 3,50x
EV / Sales2017 3,16x
Capitalization 836 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
11/15Earnings Release
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
06/28 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a pharmaceuti..
2015 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Datos de cierre ..
2015 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2013 FAES FARMA SA : Statement 07/24/2013 (24 k.). January-June results.
2012 FAES FARMA SA : Statement 13/12/2012 (20 k). Faes Farma licences bilastine for S..
2012 FAES FARMA SA : Statement 02/07/2012 (19 k). FAES FARMA S.A. informs of the appr..
More news
Sector news : Pharmaceuticals - NEC
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJBAYER : 2Q 2016 -- Forecast
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
More sector news : Pharmaceuticals - NEC
Advertisement
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Technical analysis trends FAES FARMA SA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 3,17 €
Spread / Average Target -3,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gonzalo López Casanueva Co-Managing Director
Francisco Quintanilla Guerra Co-Managing Director
Mariano Ucar Angulo Chairman
Valentín Ruiz Unamunzaga Deputy MD & Director-Corporate Finance
Isidro Hermo Blanco Manager-Pharmaceutical Technology
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FAES FARMA SA18.84%918
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.13%219 526
ROCHE HOLDING LTD.-9.62%218 832
MERCK & CO., INC.11.36%162 815
More Results